Bradford T. Whitmore, 10% Owner at Clearside Biomedical, Inc. (CLSD), bought 888,888 shares at $1.35 ($1.2M) on 2024-02-07, disclosed to the SEC on 2024-02-09.
Open-market purchase of $1.2M CLSD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.35 | 444,444 | $600K | 50.0% |
| 2 | $1.35 | 444,444 | $600K | 50.0% |
| Total | $1.35 avg | 888,888 | $1.2M | 100% |
| Filing → |
| ULBI | BUY | 2025-12-16 | $602K | — | Filing → |
| ULBI | BUY | 2025-11-21 | $268K | — | Filing → |
| ULBI | BUY | 2025-08-21 | $689K | — | Filing → |